<DOC>
	<DOCNO>NCT02259985</DOCNO>
	<brief_summary>food interaction , pharmacokinetics , safety tolerability</brief_summary>
	<brief_title>Effects Food Bioavailability Pharmacokinetic Profile Itasetron After Single Oral Dose Healthy Male Subjects</brief_title>
	<detailed_description />
	<criteria>participant study range 21 50 year age within + 20 % normal weight ( Brocaindex ) write informed consent accordance Good Clinical Practica local legislation Subjects exclude study result medical examination laboratory test judge investigator differ significantly normal clinical value Subjects known gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Subjects diseases central nervous system ( epilepsy ) psychiatric disorder Subjects known history orthostatic hypotension , faint spell blackouts Subjects chronic relevant acute infection Subjects history allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator Subjects take drug long halflife ( &gt; = 24 hour ) within one month enrolment study Subjects receive drug might influence result trial week previous start study Subjects participate another study investigational drug within last 2 month precede study Subjects unable refrain smoking study day Subjects smoke 10 cigarette ( 3 cigar pipe ) per day Subjects drink 60 g alcohol per day Subjects dependent drug Subjects donate blood ( &gt; = 100 ml ) within last 4 week Subjects participate excessive physical activity ( e.g . competitive sport ) within last week study</criteria>
	<gender>Male</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>